Vincent Buchheit

Population Pharmacokinetics of Obinutuzumab (GA101) in Chronic Lymphocytic Leukemia (CLL) and Non‐Hodgkin's Lymphoma and Exposure–Response in CLL

Ekaterina Gibiansky, Leonid Gibiansky, David Carlile et al. · CPT Pharmacometrics & Systems Pharmacology · 2014 · 85 citations · Full text

Chronic Lymphocytic Leukemia, Immunology, Pharmacotherapy +17

Characterization of the pharmacokinetics of entrectinib and its active M5 metabolite in healthy volunteers and patients with solid tumors

Georgina Meneses‐Lorente, Darren Bentley, Elena Guerini et al. · Investigational New Drugs · 2021 · 38 citations · Full text

In vitro and clinical investigations to determine the drug-drug interaction potential of entrectinib, a small molecule inhibitor of neurotrophic tyrosine receptor kinase (NTRK)

Georgina Meneses‐Lorente, Stephen Fowler, Elena Guerini et al. · Investigational New Drugs · 2021 · 18 citations · Full text

Physiologically-Based Pharmacokinetic Modelling of Entrectinib Parent and Active Metabolite to Support Regulatory Decision-Making

Nassim Djebli, Vincent Buchheit, Neil Parrott et al. · European Journal of Drug Metabolism and Pharmacokinetics · 2021 · 14 citations

Medicinal Chemistry, Support Regulatory Decision-making, Pharmacokinetic Modeling +15

Population pharmacokinetic analysis of entrectinib in pediatric and adult patients with advanced/metastatic solid tumors: support of new drug application submission

Mario González‐Sales, Nassim Djebli, Georgina Meneses‐Lorente et al. · Cancer Chemotherapy and Pharmacology · 2021 · 13 citations

Oncology, Medicine, Adult Patients +7